Search

everythinglearnresearchcommunity

for

Search:↓

Topical GT20029 effectively promotes hair regrowth and is well-tolerated for treating androgenetic alopecia.

Waiting for a perfect study is futile; instead, use a clinical registry and collect data incrementally to improve wound treatment knowledge.

Drug repurposing offers a faster, cheaper way to find treatments for rare diseases.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

Single-spin PRP may be more effective for treating hair loss.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Presurgical models can effectively and affordably screen cancer prevention agents.

Low dose cyclical nutrition therapy can consistently and safely improve hair growth and density without needing anti-androgens.

Serial trichoscopy is more reliable than the modified hair pull test for tracking alopecia areata.

Low-penetration genes might help personalize colorectal cancer prevention.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

No treatment showed significant long-term hair growth benefits for alopecia areata.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Sublingual minoxidil safely increases hair growth in transgender people on testosterone therapy.

Polyphenolic compounds may help hair growth but need more research.

Clinical trials for alopecia areata need better inclusion and retention of patients of color.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Social media can help compare the effectiveness and safety of new arthritis medications.

Niosomal minoxidil was found to be more effective in increasing hair count and patient satisfaction than conventional minoxidil in treating hair loss.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

PRP treatment significantly increases hair density in men with androgenetic alopecia.

Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.